Renal cytochrome P450 as a determinant of impaired natriuresis by PPAR-γ ligands in ovariectomized obese rats

Kyoko Yoshioka, Shu Wakino, Koichiro Honma, Takeshi Kanda, Satoru Tatematsu, Kazuhiro Hasegawa, Naoki Sugano, Osamu Ito, Ken Omata, Takao Saruta, Koichi Hayashi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: Peroxisome proliferator-activated receptor (PPAR)-γ ligand, pioglitazone (PIO), is reported to induce edema especially in postmenopausal women. The aim of this study was to elucidate the mechanism for PIO-induced sodium retention and to discover the therapeutic strategy for the PIO-induced changes in renal sodium handling. Methods and Procedures: Zucker obese rats were ovariectomized and were given PIO for 8 weeks. Renal sodium excretion and renal expressions of several enzymes that generate natriuretic substances were examined. Results: Sodium excretion was decreased in ovariectomized (OVX) rats that were given PIO when compared with OVX rats that were not. Urinary nitrites/nitrates excretion was decreased in OVX rats, but was restored by PIO. The expressions of nitric oxide synthases (NOSs) and cyclooxygenases-1/2 (COX-1/2) were unaltered. Similarly, the expression of epithelial sodium channels (ENaC), identified as a PPAR-γ-regulated gene product, was unaffected. In contrast, the expression of cytochrome P450 4A (CYP4A) was increased in OVX rats, and was downregulated by PIO. Co-treatment of OVX rats with PIO and PPAR-α ligand, fenofibrate, a putative inducer of CYP4A, restored not only the impaired sodium excretion but also the downregulated CYP4A expression. Discussion: PIO-induced sodium retention is specific in female OVX rats. Ovariectomy decreases renal NO production, but upregulates renal CYP4A expression to compensate for renal sodium balance. In this setting, PIO downregulates CYP4A, leading to sodium retention. Furthermore, PPAR-α ligands can provide a novel strategy for preventing the PIO-induced sodium retention.

Original languageEnglish
Pages (from-to)965-971
Number of pages7
JournalObesity
Volume16
Issue number5
DOIs
Publication statusPublished - 2008 May

Fingerprint

pioglitazone
Natriuresis
Peroxisome Proliferator-Activated Receptors
Cytochrome P-450 Enzyme System
Ligands
Kidney
Sodium
Down-Regulation
Fenofibrate
Epithelial Sodium Channels
Zucker Rats

ASJC Scopus subject areas

  • Endocrinology
  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Renal cytochrome P450 as a determinant of impaired natriuresis by PPAR-γ ligands in ovariectomized obese rats. / Yoshioka, Kyoko; Wakino, Shu; Honma, Koichiro; Kanda, Takeshi; Tatematsu, Satoru; Hasegawa, Kazuhiro; Sugano, Naoki; Ito, Osamu; Omata, Ken; Saruta, Takao; Hayashi, Koichi.

In: Obesity, Vol. 16, No. 5, 05.2008, p. 965-971.

Research output: Contribution to journalArticle

Yoshioka, Kyoko ; Wakino, Shu ; Honma, Koichiro ; Kanda, Takeshi ; Tatematsu, Satoru ; Hasegawa, Kazuhiro ; Sugano, Naoki ; Ito, Osamu ; Omata, Ken ; Saruta, Takao ; Hayashi, Koichi. / Renal cytochrome P450 as a determinant of impaired natriuresis by PPAR-γ ligands in ovariectomized obese rats. In: Obesity. 2008 ; Vol. 16, No. 5. pp. 965-971.
@article{b88b583577a549ceaa78d7779d93584b,
title = "Renal cytochrome P450 as a determinant of impaired natriuresis by PPAR-γ ligands in ovariectomized obese rats",
abstract = "Objective: Peroxisome proliferator-activated receptor (PPAR)-γ ligand, pioglitazone (PIO), is reported to induce edema especially in postmenopausal women. The aim of this study was to elucidate the mechanism for PIO-induced sodium retention and to discover the therapeutic strategy for the PIO-induced changes in renal sodium handling. Methods and Procedures: Zucker obese rats were ovariectomized and were given PIO for 8 weeks. Renal sodium excretion and renal expressions of several enzymes that generate natriuretic substances were examined. Results: Sodium excretion was decreased in ovariectomized (OVX) rats that were given PIO when compared with OVX rats that were not. Urinary nitrites/nitrates excretion was decreased in OVX rats, but was restored by PIO. The expressions of nitric oxide synthases (NOSs) and cyclooxygenases-1/2 (COX-1/2) were unaltered. Similarly, the expression of epithelial sodium channels (ENaC), identified as a PPAR-γ-regulated gene product, was unaffected. In contrast, the expression of cytochrome P450 4A (CYP4A) was increased in OVX rats, and was downregulated by PIO. Co-treatment of OVX rats with PIO and PPAR-α ligand, fenofibrate, a putative inducer of CYP4A, restored not only the impaired sodium excretion but also the downregulated CYP4A expression. Discussion: PIO-induced sodium retention is specific in female OVX rats. Ovariectomy decreases renal NO production, but upregulates renal CYP4A expression to compensate for renal sodium balance. In this setting, PIO downregulates CYP4A, leading to sodium retention. Furthermore, PPAR-α ligands can provide a novel strategy for preventing the PIO-induced sodium retention.",
author = "Kyoko Yoshioka and Shu Wakino and Koichiro Honma and Takeshi Kanda and Satoru Tatematsu and Kazuhiro Hasegawa and Naoki Sugano and Osamu Ito and Ken Omata and Takao Saruta and Koichi Hayashi",
year = "2008",
month = "5",
doi = "10.1038/oby.2008.18",
language = "English",
volume = "16",
pages = "965--971",
journal = "Obesity",
issn = "1930-7381",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Renal cytochrome P450 as a determinant of impaired natriuresis by PPAR-γ ligands in ovariectomized obese rats

AU - Yoshioka, Kyoko

AU - Wakino, Shu

AU - Honma, Koichiro

AU - Kanda, Takeshi

AU - Tatematsu, Satoru

AU - Hasegawa, Kazuhiro

AU - Sugano, Naoki

AU - Ito, Osamu

AU - Omata, Ken

AU - Saruta, Takao

AU - Hayashi, Koichi

PY - 2008/5

Y1 - 2008/5

N2 - Objective: Peroxisome proliferator-activated receptor (PPAR)-γ ligand, pioglitazone (PIO), is reported to induce edema especially in postmenopausal women. The aim of this study was to elucidate the mechanism for PIO-induced sodium retention and to discover the therapeutic strategy for the PIO-induced changes in renal sodium handling. Methods and Procedures: Zucker obese rats were ovariectomized and were given PIO for 8 weeks. Renal sodium excretion and renal expressions of several enzymes that generate natriuretic substances were examined. Results: Sodium excretion was decreased in ovariectomized (OVX) rats that were given PIO when compared with OVX rats that were not. Urinary nitrites/nitrates excretion was decreased in OVX rats, but was restored by PIO. The expressions of nitric oxide synthases (NOSs) and cyclooxygenases-1/2 (COX-1/2) were unaltered. Similarly, the expression of epithelial sodium channels (ENaC), identified as a PPAR-γ-regulated gene product, was unaffected. In contrast, the expression of cytochrome P450 4A (CYP4A) was increased in OVX rats, and was downregulated by PIO. Co-treatment of OVX rats with PIO and PPAR-α ligand, fenofibrate, a putative inducer of CYP4A, restored not only the impaired sodium excretion but also the downregulated CYP4A expression. Discussion: PIO-induced sodium retention is specific in female OVX rats. Ovariectomy decreases renal NO production, but upregulates renal CYP4A expression to compensate for renal sodium balance. In this setting, PIO downregulates CYP4A, leading to sodium retention. Furthermore, PPAR-α ligands can provide a novel strategy for preventing the PIO-induced sodium retention.

AB - Objective: Peroxisome proliferator-activated receptor (PPAR)-γ ligand, pioglitazone (PIO), is reported to induce edema especially in postmenopausal women. The aim of this study was to elucidate the mechanism for PIO-induced sodium retention and to discover the therapeutic strategy for the PIO-induced changes in renal sodium handling. Methods and Procedures: Zucker obese rats were ovariectomized and were given PIO for 8 weeks. Renal sodium excretion and renal expressions of several enzymes that generate natriuretic substances were examined. Results: Sodium excretion was decreased in ovariectomized (OVX) rats that were given PIO when compared with OVX rats that were not. Urinary nitrites/nitrates excretion was decreased in OVX rats, but was restored by PIO. The expressions of nitric oxide synthases (NOSs) and cyclooxygenases-1/2 (COX-1/2) were unaltered. Similarly, the expression of epithelial sodium channels (ENaC), identified as a PPAR-γ-regulated gene product, was unaffected. In contrast, the expression of cytochrome P450 4A (CYP4A) was increased in OVX rats, and was downregulated by PIO. Co-treatment of OVX rats with PIO and PPAR-α ligand, fenofibrate, a putative inducer of CYP4A, restored not only the impaired sodium excretion but also the downregulated CYP4A expression. Discussion: PIO-induced sodium retention is specific in female OVX rats. Ovariectomy decreases renal NO production, but upregulates renal CYP4A expression to compensate for renal sodium balance. In this setting, PIO downregulates CYP4A, leading to sodium retention. Furthermore, PPAR-α ligands can provide a novel strategy for preventing the PIO-induced sodium retention.

UR - http://www.scopus.com/inward/record.url?scp=42949111533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42949111533&partnerID=8YFLogxK

U2 - 10.1038/oby.2008.18

DO - 10.1038/oby.2008.18

M3 - Article

C2 - 18277387

AN - SCOPUS:42949111533

VL - 16

SP - 965

EP - 971

JO - Obesity

JF - Obesity

SN - 1930-7381

IS - 5

ER -